Protein detail

SUIS

Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]

Protein symbol
SUIS
UniProt ID
EVMP score
0.38
Frequency
Transmembrane count
1
Protein classification
Disease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteins
Basic Information
Protein Names
Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]
Protein Class
Disease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted membrane proteins
Protein Function
  • Human disease related genes:Congenital disorders of metabolism:Congenital disorders of carbohydrate metabolism
  • Enzymes
  • ENZYME proteins:Hydrolases
  • Disease related genes
  • FDA approved drug targets:Small molecule drugs
Transmembrane
13..32; Helical; Signal-anchor for type II membrane protein
Transmembrane Count
1
Entrez Gene Symbol
Gene Description
Sucrase-isomaltase
Chromosome
3
Position
164978898-165078496
EVMP Score
0.38
Fluorescence & Localization
Cell SpecificMyonuclei
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

3 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
SIPRKACAP17612S7phosphorylationphosphoELM_MIMPMIMPHPRD_MIMPHPRDKEAHPRD:8521865KEA:8521865
SIPRKXP51817S7phosphorylationMIMPHPRD_MIMPphosphoELM_MIMP
SIPRKYO43930S7phosphorylationMIMPHPRD_MIMPphosphoELM_MIMP

Ligand-Receptor Signaling

19 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
apical_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
apical_cell_membraneplasma_membraneRamilowski_locationNoNoNoNoNo
plasma_membraneplasma_membraneRamilowski_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
transmembranetransmembrane_predictedPhobiusNoNoNoNoNo
transmembrane_phobiustransmembrane_predictedAlmen2009NoNoNoNoNo
transmembrane_sosuitransmembrane_predictedAlmen2009NoNoNoNoNo
transmembrane_tmhmmtransmembrane_predictedAlmen2009NoNoNoNoNo
Page 2 of 2Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

432 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
EYA1-SIX1 complexEYA1SIX1Q15475Q995020:0CORUMCORUM:736311734542
EYA1-SIX2 complexEYA1SIX2Q99502Q9NPC80:0CORUMhu.MAP2CORUM:736411734542
Ecsit complex (ECSITMT-CO2NDUFA1MT-ND1TRAF6NDUFAF1)ECSITMT-CO2MT-ND1NDUFA1NDUFAF1TRAF6O15239P00403P03886Q9BQ95Q9Y375Q9Y4K31:1:1:1:1:1CompleatCORUMCORUM:2939Compleat:HC76917344420
Ecsit complex (ECSITNDUFS3NDUFAF1)ECSITNDUFAF1NDUFS3O75489Q9BQ95Q9Y3751:1:1CompleatCORUMCompleat:HC454CORUM:294217344420
Ecsit complex (ECSITNDUFS3TOM20)ECSITNDUFS3TOMM20O75489Q15388Q9BQ951:1:1CompleatCORUMCompleat:HC2672CORUM:293817344420
Ecsit complex (Ecsit2-Smad1)ECSITSMAD1SMAD5SMAD9O15198Q15797Q99717Q9BQ951:1:1:1CompleatCompleat:HC316114633973
Ecsit complex (Ecsit2-Smad4)ECSITSMAD4Q13485Q9BQ951:1CompleatCompleat:HC135414633973
Ecsit complex (Smad1-Smad4-Ecsit2)ECSITSMAD1SMAD4SMAD5SMAD9O15198Q13485Q15797Q99717Q9BQ951:1:1:1:1CompleatCompleat:HC141514633973
Eya1/3-Dach1/2-Six1 complexDACH1DACH2EYA1EYA2EYA3SIX1O00167Q15475Q96NX9Q99502Q99504Q9UI361:1:1:1:1:1CompleatCompleat:HC62914628042
FOXO1-FHL2-SIRT1 complexFHL2FOXO1SIRT1Q12778Q14192Q96EB61:1:1CompleatCORUMCORUM:2590Compleat:HC54915692560
Page 2 of 44PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry132331267
Sequence, Structure & Domains

Sequences

Length
1,827
Mass
209,453
Sequence
MARKKFSGLEISLIVLFVIVTIIAIALIVVLATKTPAVDEISDSTSTPATTRVTTNPSDSGKCPNVLNDPVNVRINCIPEQFPTEGICAQRGCCWRPWNDSLIPWCFFVDNHGYNVQDMTTTSIGVEAKLNRIPSPTLFGNDINSVLFTTQNQTPNRFRFKITDPNNRRYEVPHQYVKEFTGPTVSDTLYDVKVAQNPFSIQVIRKSNGKTLFDTSIGPLVYSDQYLQISTRLPSDYIYGIGEQVHKRFRHDLSWKTWPIFTRDQLPGDNNNNLYGHQTFFMCIEDTSGKSFGVFLMNSNAMEIFIQPTPIVTYRVTGGILDFYILLGDTPEQVVQQYQQLVGLPAMPAYWNLGFQLSRWNYKSLDVVKEVVRRNREAGIPFDTQVTDIDYMEDKKDFTYDQVAFNGLPQFVQDLHDHGQKYVIILDPAISIGRRANGTTYATYERGNTQHVWINESDGSTPIIGEVWPGLTVYPDFTNPNCIDWWANECSIFHQEVQYDGLWIDMNEVSSFIQGSTKGCNVNKLNYPPFTPDILDKLMYSKTICMDAVQNWGKQYDVHSLYGYSMAIATEQAVQKVFPNKRSFILTRSTFAGSGRHAAHWLGDNTASWEQMEWSITGMLEFSLFGIPLVGADICGFVAETTEELCRRWMQLGAFYPFSRNHNSDGYEHQDPAFFGQNSLLVKSSRQYLTIRYTLLPFLYTLFYKAHVFGETVARPVLHEFYEDTNSWIEDTEFLWGPALLITPVLKQGADTVSAYIPDAIWYDYESGAKRPWRKQRVDMYLPADKIGLHLRGGYIIPIQEPDVTTTASRKNPLGLIVALGENNTAKGDFFWDDGETKDTIQNGNYILYTFSVSNNTLDIVCTHSSYQEGTTLAFQTVKILGLTDSVTEVRVAENNQPMNAHSNFTYDASNQVLLIADLKLNLGRNFSVQWNQIFSENERFNCYPDADLATEQKCTQRGCVWRTGSSLSKAPECYFPRQDNSYSVNSARYSSMGITADLQLNTANARIKLPSDPISTLRVEVKYHKNDMLQFKIYDPQKKRYEVPVPLNIPTTPISTYEDRLYDVEIKENPFGIQIRRRSSGRVIWDSWLPGFAFNDQFIQISTRLPSEYIYGFGEVEHTAFKRDLNWNTWGMFTRDQPPGYKLNSYGFHPYYMALEEEGNAHGVFLLNSNAMDVTFQPTPALTYRTVGGILDFYMFLGPTPEVATKQYHEVIGHPVMPAYWALGFQLCRYGYANTSEVRELYDAMVAANIPYDVQYTDIDYMERQLDFTIGEAFQDLPQFVDKIRGEGMRYIIILDPAISGNETKTYPAFERGQQNDVFVKWPNTNDICWAKVWPDLPNITIDKTLTEDEAVNASRAHVAFPDFFRTSTAEWWAREIVDFYNEKMKFDGLWIDMNEPSSFVNGTTTNQCRNDELNYPPYFPELTKRTDGLHFRTICMEAEQILSDGTSVLHYDVHNLYGWSQMKPTHDALQKTTGKRGIVISRSTYPTSGRWGGHWLGDNYARWDNMDKSIIGMMEFSLFGMSYTGADICGFFNNSEYHLCTRWMQLGAFYPYSRNHNIANTRRQDPASWNETFAEMSRNILNIRYTLLPYFYTQMHEIHANGGTVIRPLLHEFFDEKPTWDIFKQFLWGPAFMVTPVLEPYVQTVNAYVPNARWFDYHTGKDIGVRGQFQTFNASYDTINLHVRGGHILPCQEPAQNTFYSRQKHMKLIVAADDNQMAQGSLFWDDGESIDTYERDLYLSVQFNLNQTTLTSTILKRGYINKSETRLGSLHVWGKGTTPVNAVTLTYNGNKNSLPFNEDTTNMILRIDLTTHNVTLEEPIEINWS

3D Structural Models

Turn
196..199; 206..209; 308..310; 402..407; 507..509; 524..526; 539..542; 737..739; 765..767; 909..912
Helix
71..73; 85..91; 215..217; 331..342; 350..353; 365..377; 389..391; 393..395; 408..417; 442..450; 480..496; 535..537; 555..558; 559..561; 562..577; 594..596; 609..624; 643..653; 672..675; 680..694; 696..709; 718..721; 725..729; 806..809; 840..843; 868..872
Beta Strand
65..68; 75..77; 99..103; 105..107; 114..121; 123..132; 138..140; 144..154; 157..163; 175..177; 189..195; 200..205; 210..214; 221..223; 226..232; 234..236; 238..244; 247..250; 254..261; 278..284; 291..296; 302..307; 311..319; 321..330; 384..387; 421..426; 459..462; 465..467; 470..473; 500..504; 512..515; 585..588; 599..601; 606..608; 629..631; 637..639; 656..658; 713..715; 732..736; 740..743; 751..757; 762..764; 775..781; 788..792; 795..800; 814..819; 824..832; 835..837; 846..854; 857..865; 874..882; 890..894; 900..902; 905..908; 913..916; 927..930
3D Structure
X-ray crystallography (2)

Domain & Motif Annotations

Compositional Bias
45..55; Low complexity
Domain (FT)
61..110; P-type 1; 932..978; P-type 2
Region
40..61; Disordered; 110..1007; Isomaltase; 1008..1827; Sucrase
Protein Families
Glycosyl hydrolase 31 family
Sequence Similarities
Belongs to the glycosyl hydrolase 31 family.
Clinical Relevance
Disease Involvement
Disease variantFDA approved drug targets
Drug Targets
FDA approved drug targets
Antibody